Red Flags Detected
- Departure Of Cfo (new) — Interim CFO Thomas McGauley resigned effective May 10, 2026, though he will continue consulting through month-end to support the transition.
Tenax Therapeutics appoints Thomas R. Staab as CFO with $428K salary, 450K stock options
Filed April 22, 2026 · Period ending April 22, 2026 · ~1 min read
4 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade TENX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 5:07 PM